DCP Slots allocation

A DCP slot is a time interval in which it is possible to submit an application for marketing authorisation of a medicinal product within a DCP to SÚKL as the RMS and to the agencies of the Concerned Member States. A DCP slot is newly allocated for each half of the calendar month. The application for marketing authorisation has to be submitted within the half of the month that has been allocated.

SÚKL allocates DCP slots to applications for marketing authorisation of a medicinal product with all types of legal basis 2 years in advance.

Requests for DCP slots allocation

It is advisable to ask for a DCP slot at least two months prior to the planned submission of the marketing authorisation application with SÚKL as the RMS, taking into account the free capacities specified in the table of free capacities below. This table specifies currently available free capacities for DCP slots for the following months; nevertheless, it is possible to apply for a DCP slot allocation as long as 2 years in advance. Slots are allocated either for the first or the last two weeks in a calendar month.

Furthermore, it is necessary to apply for a DCP slot in case of applications for marketing authorisation through line extensions and so-called duplicates.

Note: Submission of duplicates concurrently with the “primary” DCP procedure should be planned before sending of the request for the DCP slot, as these duplicates must be included directly in the Request Form for the DCP slot of this “primary” DCP procedure and this Request Form should not be changed after the appropriate DCP slot is allocated. Subsequent supplementation of the Request Form with duplicates may cause the postponement of the already allocated DCP slot due to lack of free capacities.

Free capacities for DCP slot allocation:

Requests for DCP slots are to be submitted using a fully completed “Request for RMS in a Decentralised Procedure, medicinal products for human use” available as the Common Request form. The preferred timeline for submission of the marketing authorisation application has to be specified in the month (1^st or 2^nd half)  and year format (rather than the quarter and years format). If an outdated Request Form is used, the request will not be considered valid and applicants will be asked for update.

The request submitted on the Common Request form has to be sent to the following e-mail address: DCP.slot@sukl.gov.cz.

The request should be sent at least 2 months before the planned date of submission of the marketing authorisation application.

Concurrently, applicants are invited to wait for the reply regarding DCP slot allocation from SÚKL prior to submitting a request for a DCP slot in another EU medicines agency.

Procedure for DCP slots allocation

The applicant will be informed about the allocated slot within 2 weeks of sending the fully completed request for a DCP slot. In case it is not possible to accept the DCP slot date proposed by the applicant, SÚKL shall propose an alternative one. Please note that the table of free capacities for DCP slot allocations above reflects only confirmed DCP slot requests, not all currently submitted requests.

Thereafter, within one week of receiving the information on DCP slot allocation (or an alternative date, if applicable), the applicant has to confirm whether they accept the DCP slot date or not. Should SÚKL fail to receive any confirmation within a week of having sent the information on the allocated DCP slot date, the slot shall be considered free again.

Changes to allocated DCP slots

DCP slot postponement: The applicant shall apply for a DCP slot postponement as soon as practicable; the request shall be sent by e-mail to the following e-mail address: DCP.slot@sukl.gov.cz. The applicant shall be informed about the postponement within 2 weeks of sending the request.

DCP slot cancellation: The applicant should inform SÚKL about the cancellation of the DCP slot as soon as practicable.

Change to a DCP slot: In case a change to an existing slot (such as a change of the active substance, legal basis, pharmaceutical form) occurs, the applicant shall apply for a new DCP slot allocation. The allocation procedure is the same as described above. Concurrently, it is necessary to inform about the cancellation of the originally allocated DCP slot.

Applications for the conduct of a MRP/RUP with SÚKL as the RMS

SÚKL asks marketing authorisation holders to inform about their intention to submit an application for the conduct of a Mutual Recognition Procedure (MRP/RUP) with SÚKL as the RMS at least one month prior to the submission of the application.

The maximum capacity of MRP / RUP applications with SÚKL as RMS is 3 applications per month.

Requirements for submission of applications for conduct of a MRP/RUP with SÚKL as RMS are available here.